image
Healthcare - Medical - Devices - NASDAQ - US
$ 15.03
-2.97 %
$ 95.1 M
Market Cap
9.82
P/E
1. INTRINSIC VALUE

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies.[ Read More ]

The intrinsic value of one FONR stock under the base case scenario is HIDDEN Compared to the current market price of 15 USD, FONAR Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart FONR

image
FINANCIALS
103 M REVENUE
4.30%
16.5 M OPERATING INCOME
11.81%
14.1 M NET INCOME
16.25%
14.1 M OPERATING CASH FLOW
-2.58%
-851 K INVESTING CASH FLOW
80.39%
-8.18 M FINANCING CASH FLOW
-8.04%
2.02 M REVENUE
-92.20%
4.61 M OPERATING INCOME
245.44%
4 M NET INCOME
144.74%
1.66 M OPERATING CASH FLOW
-63.96%
-1.82 M INVESTING CASH FLOW
-419.82%
-1.99 M FINANCING CASH FLOW
-5.24%
Balance Sheet Decomposition FONAR Corporation
image
Current Assets 140 M
Cash & Short-Term Investments 56.5 M
Receivables 79.8 M
Other Current Assets 4 M
Non-Current Assets 73.9 M
Long-Term Investments 0
PP&E 57.7 M
Other Non-Current Assets 16.3 M
Current Liabilities 17.9 M
Accounts Payable 1.86 M
Short-Term Debt 3.75 M
Other Current Liabilities 12.3 M
Non-Current Liabilities 39.6 M
Long-Term Debt 37.9 M
Other Non-Current Liabilities 1.67 M
EFFICIENCY
Earnings Waterfall FONAR Corporation
image
Revenue 103 M
Cost Of Revenue 57.7 M
Gross Profit 45.1 M
Operating Expenses 28.6 M
Operating Income 16.5 M
Other Expenses 2.44 M
Net Income 14.1 M
RATIOS
43.87% GROSS MARGIN
43.87%
16.07% OPERATING MARGIN
16.07%
10.27% NET MARGIN
10.27%
6.37% ROE
6.37%
4.93% ROA
4.93%
7.29% ROIC
7.29%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis FONAR Corporation
image
Net Income 14.1 M
Depreciation & Amortization 8.91 M
Capital Expenditures -823 K
Stock-Based Compensation 0
Change in Working Capital -13.2 M
Others -163 K
Free Cash Flow 13.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets FONAR Corporation
image
FONR has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.189 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership FONAR Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 years ago
Sep 30, 2022
Bought 48.1 K USD
Bonanni Luciano B
Exec VP, COO & PFO
+ 3400
14.16 USD
2 years ago
Sep 29, 2022
Bought 18 K USD
Bonanni Luciano B
Exec VP, COO & PFO
+ 1300
13.82 USD
2 years ago
Sep 30, 2022
Bought 31.1 K USD
Damadian Timothy Raymond
CEO, President & Treasurer
+ 2200
14.15 USD
2 years ago
Sep 29, 2022
Bought 34.1 K USD
Damadian Timothy Raymond
CEO, President & Treasurer
+ 2500
13.63 USD
6 years ago
Sep 26, 2018
Sell 11.1 K USD
Damadian Raymond V
Treasurer
- 450
24.7 USD
6 years ago
Sep 27, 2018
Sell 11.1 K USD
Damadian Raymond V
Treasurer
- 450
24.65 USD
6 years ago
Sep 24, 2018
Sell 36.6 K USD
Damadian Raymond V
Treasurer
- 1500
24.4 USD
6 years ago
Sep 24, 2018
Sell 7.34 K USD
Damadian Raymond V
Treasurer
- 300
24.45 USD
6 years ago
Sep 25, 2018
Sell 7.42 K USD
Damadian Raymond V
Treasurer
- 300
24.75 USD
6 years ago
Sep 25, 2018
Sell 7.44 K USD
Damadian Raymond V
Treasurer
- 300
24.8 USD
6 years ago
Jun 28, 2018
Sell 16.1 K USD
Damadian Raymond V
Treasurer
- 607
26.46 USD
6 years ago
Jun 29, 2018
Sell 16.8 K USD
Damadian Raymond V
Treasurer
- 633
26.58 USD
6 years ago
Jun 26, 2018
Sell 17.1 K USD
Damadian Raymond V
Treasurer
- 620
27.58 USD
6 years ago
Jun 27, 2018
Sell 16.8 K USD
Damadian Raymond V
Treasurer
- 620
27.15 USD
6 years ago
Jun 22, 2018
Sell 19.3 K USD
Damadian Raymond V
Treasurer
- 700
27.6 USD
6 years ago
Jun 25, 2018
Sell 16.9 K USD
Damadian Raymond V
Treasurer
- 620
27.32 USD
6 years ago
Jun 20, 2018
Sell 16.6 K USD
Damadian Raymond V
Treasurer
- 600
27.605 USD
6 years ago
Jun 21, 2018
Sell 16.4 K USD
Damadian Raymond V
Treasurer
- 600
27.25 USD
6 years ago
Feb 20, 2018
Sell 25.7 K USD
Janoff Robert J
Director
- 1000
25.73 USD
8 years ago
Jun 16, 2016
Sell 51.5 K USD
Damadian Raymond V
TREASURER
- 2700
19.09 USD
8 years ago
Apr 14, 2016
Sell 30 K USD
Damadian Raymond V
Treasurer
- 2000
15.01 USD
9 years ago
May 22, 2015
Sell 48.5 K USD
Damadian Raymond V
President
- 4550
10.664 USD
10 years ago
Jan 09, 2014
Sell 26.3 K USD
Janoff Robert J
Director
- 1000
26.32 USD
10 years ago
Dec 13, 2013
Sell 50 K USD
Damadian Raymond V
Chairman, President
- 3350
14.93 USD
11 years ago
Jun 19, 2013
Sell 24.7 K USD
Damadian Raymond V
President, Chairman
- 4000
6.18 USD
12 years ago
Jan 18, 2012
Bought 880 USD
O Data Charles
Director
+ 500
1.76 USD
13 years ago
Apr 28, 2011
Bought 188 USD
Janoff Robert J
Director
+ 101
1.86 USD
16 years ago
Oct 17, 2008
Sell 112 USD
Janoff Robert J
Director
- 150
0.75 USD
16 years ago
Oct 20, 2008
Sell 412 USD
Janoff Robert J
Director
- 550
0.75 USD
17 years ago
May 15, 2007
Bought 54.7 K USD
Damadian Raymond V
president
+ 8500
6.44 USD
18 years ago
May 30, 2006
Bought 50 K USD
Damadian Raymond V
president
+ 116279
0.43 USD
18 years ago
May 11, 2006
Bought 50 K USD
Damadian Raymond V
president
+ 90900
0.55 USD
18 years ago
Feb 10, 2006
Bought 6.6 K USD
Janoff Robert J
Director
+ 10000
0.66 USD
18 years ago
Feb 13, 2006
Bought 59.7 K USD
Damadian Raymond V
president
+ 100000
0.5966 USD
7. News
FONR Stock Gains Despite Q1 Earnings Dip and Rising Expenses FONAR's fiscal first-quarter earnings reveals a decline in revenues and income, driven by decreased patient fees and rising costs, while MRI scan volume sees modest growth. zacks.com - 3 days ago
Fonar Announces Financial Results for the 1st Quarter of Fiscal 2025 Total MRI scan volume at the HMCA-managed sites increased 5% to 53,054 scans for the quarter ending September 30, 2024 versus the corresponding quarter one year earlier. Cash and cash equivalents decreased 4% to $54.2 million at September 30, 2024 as compared to the fiscal year-ended June 30, 2024. newsfilecorp.com - 5 days ago
FONR's Stock Down Despite Earnings, Revenues Uptick in Fiscal 2024 Strength in FONAR's HMCA segment's revenues drives its top line in fiscal 2024. zacks.com - 1 month ago
Fonar Announces Fiscal 2024 Financial Results Total MRI scan volume at the HMCA-managed sites increased 11% to 209,327 scans for the fiscal year ending June 30, 2024 as compared to the prior year. Cash and Cash Equivalents increased 10% to $56.3 million at June 30, 2024 versus the previous fiscal year. newsfilecorp.com - 1 month ago
FONAR Corporation: Shares Look Ready To Embark On A Sustained Bullish Run (Technical Analysis) FONAR Corporation showed encouraging growth trends in revenues and earnings, leading to a 'Buy' rating last year. Recent technical trends suggest a potential long-term change in the stock trend, supported by strong near-term growth rates and a favorable valuation. Forward-looking fundamentals, including the adoption of SwiftMR, indicate potential for continued growth and profitability for FONR shareholders. seekingalpha.com - 4 months ago
Zacks Initiates Coverage of FONAR Corporation With Outperform Recommendation Discover why Zacks rates FONAR Corporation as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore FONR's strategic expansion, financial health and market positioning for growth in the MRI diagnostic services space. zacks.com - 5 months ago
Fonar Announces Fiscal 2024 Financial Results for 3rd Quarter and Nine-Month Period Total MRI scan volume at the HMCA-managed sites increased 11% to 154,790 scans for the nine-month period ended March 31, 2024 as compared to the nine-month period ended March 31, 2023. Net Income increased 25% to $12.5 million for the nine-month period ended March 31, 2024 as compared to the nine-month period ended March 31, 2023. newsfilecorp.com - 6 months ago
FONAR: Recent Selloff Seems Unjustified As EV/EBITDA Approaches 4x The company focuses on managing diagnostic imaging centers, and it has slow and predicable revenue growth with decent margins. In my view, the Q2 FY24 results were strong as revenues inched up by 4.7% to $25.4 million while attributable net income soared by 68.4% to $3.8 million. The market capitalization of Fonar slumped by over 20% in the past month, and I think this creates a good buying opportunity here. seekingalpha.com - 7 months ago
Fonar Announces Six Months and 2nd Quarter Financial Results for Fiscal 2024 Total MRI scan volume at the HMCA-managed sites increased 13% to 101,990 scans for the six months ending December 31, 2023 versus the corresponding period one year earlier. Cash and cash equivalents and short-term investments increased 4% to $53.2 million at December 31, 2023, versus the fiscal year ended June 30, 2023. newsfilecorp.com - 9 months ago
Fonar Announces Financial Results for the 1st Quarter of Fiscal 2024 On September 13, 2022, the Company adopted a stock repurchase plan of up to $9 million. At September 30, 2023, the Company has purchased 146,359 shares at a cost of $2,473,215. newsfilecorp.com - 1 year ago
Fonar Announces Distributor Agreement with Airs Medical, Leader in AI-Powered MRI Technology Melville, New York--(Newsfile Corp. - November 8, 2023) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announces that it is now the exclusive distributor of SwiftMR™ from AIRS Medical, Inc. to FONAR customers for use on their FONAR MRIs or on any other MRI scanner they own. AIRS Medical is the leading Artificial Intelligence (AI)-powered healthcare solution provider. newsfilecorp.com - 1 year ago
FONAR Announces Financial Results for Fiscal 2023 On August 3, 2022, FONAR founder and The Father of MRI, Raymond V. Damadian, died at 86. newsfilecorp.com - 1 year ago
8. Profile Summary

FONAR Corporation FONR

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 95.1 M
Dividend Yield 0.00%
Description FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Contact 110 Marcus Drive, Melville, NY, 11747 https://www.fonar.com
IPO Date Oct. 29, 1981
Employees 520
Officers Mr. Timothy R. Damadian M.D. Chairman, President, Chief Executive Officer & Treasurer Ms. Claudette J. V. Chan Secretary & Director Mr. Daniel Culver Director of Communications Mr. Luciano B. Bonanni Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer